1.Wollmann HA. Growth hormone and growth factors during perinatal life. Horm Res. 2000; 53(Suppl 1), 50–54.
2.Suwa S, Katsumata N, Maesaka H, et al. Serum insulin-like growth factor I (somatomedin-C) level in normal subjects from infancy to adulthood, pituitary dwarfs and normal variant short children. Endocrinol. 1988; 35, 857–864.
3.Woods KA, Camacho-Hubner C, Savage MO, et al. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med. 1996; 335, 1363–1367.
4.Camacho-Hübner C, Woods KA, Miraki-Moud F, et al. Insulin-like growth factor-I deficiency caused by a partial deletion of the IGF-I gene: effects of rhIGF-I therapy. Growth Horm IGF Res. 1999; 9(Suppl B), 47–52.
5.Takahashi Y. Essential roles of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in the liver. Endocr J. 2012; 59, 955–962.
6.Conti E, Musumeci MB, De Giusti M, et al. IGF-1 and atherothrombosis: relevance to pathophysiology and therapy. Clin Sci. 2011; 120, 377–402.
7.Ungvari Z, Csiszar A. The emerging role of IGF-1 deficiency in cardiovascular aging: recent advances. J Gerontol A Biol Sci Med Sci. 2012; 67, 599–610.
8.Colao A, Spiezia S, Di Somma C, et al. Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age. J Endocrinol Invest. 2005; 28, 440–448.
9.Succurro E, Arturi F, Grembiale A, et al. Positive association between plasma IGF1 and high-density lipoprotein cholesterol levels in adult nondiabetic subjects. Eur J Endocrinol. 2010; 163, 75–80.
10.Zenobi PD, Holzmann P, Glatz Y, et al. Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I. Diabetologia. 1993; 36, 465–469.
11.Nelson SM, Freeman DJ, Sattar N, et al. IGF-1 and leptin associate with fetal HDL cholesterol at birth: examination in offspring of mothers with type 1 diabetes. Diabetes. 2007; 56, 2705–2709.
12.Guilloteau P, Zabielski R, Hammon HM, et al. Adverse effects of nutritional programming during prenatal and early postnatal life, some aspects of regulation and potential prevention and treatments. J Physiol Pharmacol. 2009; 60(Suppl 3), 17–35.
13.Hanley B, Dijane J, Fewtrell M, et al. Metabolic imprinting, programming and epigenetics – a review of present priorities and future opportunities. Br J Nutr. 2010; 104(Suppl 1), S1–S25.
14.Tosh DN, Fu Q, Callaway CW, et al. Epigenetics of programmed obesity: alteration in IUGR rat hepatic IGF1 mRNA expression and histone structure in rapid vs. delayed postnatal catch-up growth. Am J Physiol Gastrointest Liver Physiol. 2010; 299, G1023–G1029.
15.Fu Q, Yu X, Callaway CW, et al. Epigenetics: intrauterine growth retardation (IUGR) modifies the histone code along the rat hepatic IGF-1 gene. FASEB J. 2009; 23, 2438–2449.
16.Itabashi K, Fujimura M, Kusuda S, et al. Committee on Neonatal Medicine in Japan Pediatric Society. New neonatal anthropometric charts. J Jpn Pediatr Soc. 2010; 114, 1271–1293 (in Japanese).
17.Okazaki M, Usui S, Ishigami M, et al. Identification of unique lipoprotein subclasses for visceral obesity by component analysis of cholesterol profile in high-performance liquid chromatography. Arterioscler Thromb Vasc Biol. 2005; 25, 578–584.
18.Sakurabayashi I, Saito Y, Kita T, et al. Reference intervals for serum apolipoproteins A-I, A-II, B, C-II, C-III and E in healthy Japanese determined with a commercial immunoturbidimetric assay and effects of sex, age, smoking, drinking, and Lp(a) level. Clin Chim Acta. 2001; 12, 87–95.
19.Bansal N, Cruickshank JK, McElduff P, et al. Cord blood lipoproteins and prenatal influences. Curr Opin Lipidol. 2005; 16, 400–408.
20.Nagano N, Okada T, Yonezawa R, et al. Early postnatal changes of lipoprotein subclass profile in late preterm infants. Clin Chim Acta. 2012; 413, 109–112.
21.Kelishadi R, Badiee Z, Adeli K. Cord blood lipid profile and associated factors: baseline data of a birth cohort study. Paediatr Perinat Epidemiol. 2007; 21, 518–524.
22.Cai HJ, Xie CL, Chen Q, et al. The relationship between hepatic low-density lipoprotein receptor activity and serum cholesterol level in the human fetus. Hepatology. 1991; 13, 852–857.
23.Diaz M, Leal C, Ramon Y, et al. Cord blood lipoprotein-cholesterol: relationship birth weight and gestational age of newborns. Metabolism. 1989; 38, 435–438.
24.Lok F, Owens JA, Mundy L, et al. Insulin-like growth factor I promotes growth selectively in fetal sheep in late gestation. Am J Physiol. 1996; 270(Pt 2), R1148–R1155.
25.Fowden AL. The insulin-like growth factors and feto-placental growth. Placenta. 2003; 24, 803–812.
26.Ross JT, McMillen IC, Lok F, et al. Intrafetal insulin-like growth factor-I infusion stimulates adrenal growth but not steroidogenesis in the sheep fetus during late gestation. Endocrinology. 2007; 148, 5424–5432.
27.Parker CR Jr, Carr BR, Simpson ER, et al. Decline in the concentration of low-density lipoprotein-cholesterol in human fetal plasma near term. Metabolism. 1983; 32, 919–923.
28.Kaser S, Ebenbichler CF, Wolf HJ, et al. Lipoprotein profile and cholesteryl ester transfer protein in neonates. Metabolism. 2001; 50, 723–728.
29.Loukidi-Bouchenak B, Lamri-Senhadji MY, Merzouk S, et al. Serum lecithin: cholesterol acyltransferase activity, HDL2 and HDL3 composition in hypertensive mothers and their small for gestational age newborns. Eur J Pediatr. 2008; 167, 525–532.
30.Yoshikawa K, Okada T, Munakata S, et al. Association between serum lipoprotein lipase mass concentration and subcutaneous fat accumulation during neonatal period. Eur J Clin Nutr. 2010; 64, 447–453.
31.Kajantie E, Barker DJ, Osmond C, et al. Growth before 2 years of age and serum lipids 60 years later: the Helsinki Birth Cohort study. Int J Epidemiol. 2008; 37, 280–289.
32.Jensen RB, Chellakooty M, Vielwerth S, et al. Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life: does insulin-like growth factor-I play a role? Horm Res. 2003; 60(Suppl 3), 136–148.
33.IJzerman RG, Stehouwer CD, Van Weissenbruch MM, et al. Evidence for genetic factors explaining the association between birth weight and low-density lipoprotein cholesterol and possible intrauterine factors influencing the association between birth weight and high-density lipoprotein cholesterol: analysis in twins. J Clin Endocrinol Metab. 2001; 86, 5479–5484.
34.Colangelo LA, Liu K, Gapstur SM, CARDIA Male Hormone Study. Insulin-like growth factor-1, insulin-like growth factor binding protein-3, and cardiovascular disease risk factors in young black men and white men: the CARDIA Male Hormone Study. Am J Epidemiol. 2004; 160, 750–757.